The treatment of neonatal pain is a challenge to health professionals. This pain of
invasive procedures in the first hour care in the delivery room, either by manipulation or
the application of vitamin K to prevent hemorrhagic disease, among other causes. The
administration of vitamin K, although painful, is rarely accompanied by as analgesic.
Objective: To compare the efficacy of glucose 25% in pain scores in infants born at
term, underwent intramuscular administration of vitamin K. Thus evaluating the
efficacy of glucose solution in 25% pain relief by administering a single dose of 1 ml
two minutes before the painful procedure. Methods: Randomized clinical trial,
conducted at the first aid room newborn Maternity Child Health in October 2011. The
sample consisted of 150 infants, of which 75 randomized in the experimental group
(glucose) and 75 in the control group. Two minutes before being subjected to an
intramuscular injection of vitamin K, the experimental group received 1 mL of 25%
glucose orally. The primary endpoint was the assessment of heart rate, oxygen
saturation, followed by scales: Neonatal Infant Pain Scale (NIPS), Premature Infant
Paint Profile (PIPP) and Behavioral Indicators of Infant Pain (biip). The research project
was approved by the ethics committee of the Faculty of Nursing (Research Ethics
Committee-CEP). Results: ANOVA showed that the change in heart rate were less
marked in the group receiving 25% glucose, as well as the change in oxygen saturation,
thus following, the other one. Glucose 25% was effective for the relief of pain in
newborns undergoing painful procedures term administration of vitamin K. Conclusion:
The measure of analgesic oral glucose 25% was effective for the treatment of acute pain
caused by intramuscular administration of vitamin K.
|
